EA200701228A1 - Стабильные композиции фенофибрата с эфирами жирных кислот - Google Patents
Стабильные композиции фенофибрата с эфирами жирных кислотInfo
- Publication number
- EA200701228A1 EA200701228A1 EA200701228A EA200701228A EA200701228A1 EA 200701228 A1 EA200701228 A1 EA 200701228A1 EA 200701228 A EA200701228 A EA 200701228A EA 200701228 A EA200701228 A EA 200701228A EA 200701228 A1 EA200701228 A1 EA 200701228A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- fatty acid
- phenophibrate
- stable compositions
- acid ethers
- fenofibrate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63312604P | 2004-12-06 | 2004-12-06 | |
| PCT/US2005/044036 WO2006062933A2 (en) | 2004-12-06 | 2005-12-05 | Stable compositions of fenofibrate with fatty acid esters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200701228A1 true EA200701228A1 (ru) | 2007-12-28 |
Family
ID=36578470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200701228A EA200701228A1 (ru) | 2004-12-06 | 2005-12-05 | Стабильные композиции фенофибрата с эфирами жирных кислот |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060188529A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1830804A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008522972A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20070098855A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101094647A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005314197A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0518426A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2589656A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA200701228A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007006775A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20073457L (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006062933A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0513082A (pt) * | 2004-08-06 | 2008-04-22 | Transform Pharmaceuticals Inc | formulações de fenofibrato e métodos de tratamento relacionados |
| CN101098690A (zh) * | 2004-12-06 | 2008-01-02 | 瑞莱恩特医药品有限公司 | 用于血脂治疗的ω-3脂肪酸和脂血异常剂 |
| US8524280B2 (en) * | 2008-12-15 | 2013-09-03 | Banner Pharmacaps, Inc. | Methods for enhancing the release and absorption of water insoluble active agents |
| WO2010085811A2 (en) * | 2009-01-26 | 2010-07-29 | Taipei Medical University | Use of pterosin compounds for treating diabetes and obesity |
| US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
| US8715648B2 (en) | 2011-02-16 | 2014-05-06 | Pivotal Therapeutics Inc. | Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics |
| US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
| US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
| CA2916208A1 (en) | 2012-06-17 | 2013-12-27 | Matinas Biopharma, Inc. | Omega-3 pentaenoic acid compositions and methods of use |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
| GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
| US5545628A (en) * | 1995-01-10 | 1996-08-13 | Galephar P.R. Inc. | Pharmaceutical composition containing fenofibrate |
| MY118354A (en) * | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
| FR2737121B1 (fr) * | 1995-07-27 | 1997-10-03 | Cl Pharma | Nouvelles formulations galeniques du fenofibrate et leurs applications |
| FR2758459B1 (fr) * | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
| WO1998046588A2 (en) * | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| CA2313024C (en) * | 1997-12-10 | 2008-06-03 | Severson, Mary L. | Pharmaceutical compositions containing an omega-3 fatty acid oil |
| EP1140036A2 (en) * | 1998-12-18 | 2001-10-10 | Abbott Laboratories | Novel formulations comprising lipid-regulating agents |
| US6814977B1 (en) * | 1998-12-18 | 2004-11-09 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
| US7014864B1 (en) * | 1998-12-18 | 2006-03-21 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| MXPA01009839A (es) * | 1999-03-31 | 2002-06-21 | Abbott Lab | Nuevas formulaciones que comprenden agentes reguladores de lipido. |
| US6372251B2 (en) * | 1999-06-11 | 2002-04-16 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
| US6982281B1 (en) * | 2000-11-17 | 2006-01-03 | Lipocine Inc | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| FR2803203B1 (fr) * | 1999-12-31 | 2002-05-10 | Fournier Ind & Sante | Nouvelles formulations galeniques du fenofibrate |
| US6667064B2 (en) * | 2000-08-30 | 2003-12-23 | Pilot Therapeutics, Inc. | Composition and method for treatment of hypertriglyceridemia |
| FR2818905A1 (fr) * | 2000-12-28 | 2002-07-05 | Cll Pharma | Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile |
| US20040005339A1 (en) * | 2002-06-28 | 2004-01-08 | Shojaei Amir H. | Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability |
-
2005
- 2005-12-05 CA CA002589656A patent/CA2589656A1/en not_active Abandoned
- 2005-12-05 AU AU2005314197A patent/AU2005314197A1/en not_active Abandoned
- 2005-12-05 EA EA200701228A patent/EA200701228A1/ru unknown
- 2005-12-05 JP JP2007544611A patent/JP2008522972A/ja active Pending
- 2005-12-05 WO PCT/US2005/044036 patent/WO2006062933A2/en not_active Ceased
- 2005-12-05 BR BRPI0518426-6A patent/BRPI0518426A2/pt not_active IP Right Cessation
- 2005-12-05 MX MX2007006775A patent/MX2007006775A/es unknown
- 2005-12-05 KR KR1020077015607A patent/KR20070098855A/ko not_active Withdrawn
- 2005-12-05 EP EP05849159A patent/EP1830804A2/en not_active Withdrawn
- 2005-12-05 CN CNA2005800454249A patent/CN101094647A/zh active Pending
- 2005-12-05 US US11/293,496 patent/US20060188529A1/en not_active Abandoned
-
2007
- 2007-07-04 NO NO20073457A patent/NO20073457L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008522972A (ja) | 2008-07-03 |
| EP1830804A2 (en) | 2007-09-12 |
| CN101094647A (zh) | 2007-12-26 |
| WO2006062933A3 (en) | 2006-08-31 |
| KR20070098855A (ko) | 2007-10-05 |
| MX2007006775A (es) | 2008-02-25 |
| NO20073457L (no) | 2007-09-05 |
| US20060188529A1 (en) | 2006-08-24 |
| AU2005314197A1 (en) | 2006-06-15 |
| BRPI0518426A2 (pt) | 2008-11-25 |
| CA2589656A1 (en) | 2006-06-15 |
| WO2006062933A2 (en) | 2006-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200701913A1 (ru) | Лечение статином, омега-3 жирными кислотами и их комбинированным продуктом | |
| CY1108700T1 (el) | Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης | |
| AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
| EA201290596A1 (ru) | Фармацевтический состав, содержащий один или более эфиров фумаровой кислоты в разлагаемой матрице | |
| EA201500650A1 (ru) | Фенилацетат l-орнитина и способы его получения | |
| EA200870219A1 (ru) | Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения | |
| ATE509634T1 (de) | Pharmazeutische formulierungen mit incretin- peptid und aprotisch-polarem lösungsmittel | |
| IL191312A0 (en) | Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid | |
| ATE424848T1 (de) | Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen | |
| ES2494316T3 (es) | Ingrediente activo novedoso en cicatrización y uso del mismo | |
| NO20073457L (no) | Stabile sammensetninger av fenofibrat med fettsyreestere | |
| EA200901365A1 (ru) | Стабилизированная фармацевтическая композиция, содержащая прегабалин | |
| SV2008003106A (es) | Composicion farmaceutica estable que contiene docetaxel y un metodo para fabricarla | |
| AR050851A1 (es) | Conjugados de hormona del crecimiento humana y polietilenglicol ramificado con glicerol, proceso para su preparacion y metodos de uso de los mismos | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| CY1108231T1 (el) | Σταθερη στερεα δοσολογικη μορφη περιλαμβανουσα δεσμοπρεσσινη | |
| AR056465A1 (es) | Composiciones que contienen derivados de taxano | |
| UY29395A1 (es) | Formulación de medicamentos conteniendo vardenafilo. | |
| BRPI0507897A (pt) | formulação de droga sólida | |
| CL2007001748A1 (es) | Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras. | |
| BR112012015437A2 (pt) | composição tópica substancialmente anidra de armazenamento estável | |
| PE20050923A1 (es) | Composicion solida que comprende un sensibilizador de insulina, un secretagogo de insulina y un ester de acidos grasos | |
| ATE485261T1 (de) | Salicylsäurederivate | |
| ATE549016T1 (de) | Pharmazeutische zusammensetzungen mit verbesserten auflöseprofilen für schwerlösliche wirkstoffe | |
| AR048672A1 (es) | Tabletas de desintegracion que comprenden licarbazepina |